The lymphocyte homing receptor CD44 was proposed as an ovarian cancer stem cell marker but is also expressed on normal somatic cells (i.e. fibroblasts and reactive mesothelial cells) [28]. This evidence concerns the gene CD44 and ovarian carcinoma.